TALPHERA, INC. — Director's Dealing 2018

Sep 5, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2018-08-31

Reporting Person: Hamel Lawrence G (Chief Development Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-31	Common Stock	A	6876	$1.49	Acquired	24371	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	41964	Indirect

Footnotes

F1: These shares were acquired under the Company's Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

F2: Non-reportable acquisition of 1,116 shares of common stock through the Company's Employee Stock Purchase Plan.